Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 11/30/17
Due: 11/30/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers | NCT01528774 | Wolfram Samlowski | user2@example.com | None | 2016-06-30 | 2016-06-30 | 2017-06-30 | - | - | 2025-07-14 |
| Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma | NCT01565837 | Wolfram Samlowski | user2@example.com | None | 2012-08-31 | 2017-11-30 | 2018-11-30 | - | - | 2025-07-14 |